Department of Paediatric Surgery, KK Women's and Children's Hospital, 100 Bukit Timah Road, Singapore 229899, Singapore.
Department of Diagnostic and Interventional Imaging, KK Women's and Children's Hospital, 100 Bukit Timah Road, Singapore 229899, Singapore.
J Pediatr Surg. 2019 Oct;54(10):2112-2116. doi: 10.1016/j.jpedsurg.2019.01.002. Epub 2019 Jan 23.
BACKGROUND/OBJECTIVES: Variations in vascular anatomy (VIVAs) of the retroperitoneal great vessels are uncommon but can potentially complicate surgical procedures and negatively affect treatment outcomes, yet their incidence and clinical impact are poorly studied. We sought to assess the incidence and clinical impact of VIVAs of retroperitoneal great vessels in patients with retroperitoneal tumors.
We retrospectively analyzed imaging, surgical, treatment and survival data of all pediatric patients with retroperitoneal tumors who underwent resection between January 2007 and October 2016, comparing preoperative scans with corresponding intraoperative observations, and subsequent surgical outcomes.
Among 66 children with renal, adrenal and paravertebral tumors, 6 (9%) had retroperitoneal VIVAs. Retroperitoneal VIVAs were present only with right-sided tumors and significantly associated with more frequent intraoperative complications (P = 0.013). While the presence of retroperitoneal VIVAs was not directly associated with survival outcomes, relapse was more frequent in patients with VIVAs (33%) than those without (18.3%, P = 0.378), and relapse was also associated with lower overall and event-free survival (P < 0.001).
VIVAs of retroperitoneal great vessels occurred in 9% of our patients with retroperitoneal tumors. Retroperitoneal VIVAs were associated with higher rates of intraoperative complications and disease relapse but was not directly related to survival outcomes.
Retrospective review study.
Level III Retrospective comparative study.
背景/目的:腹膜后大血管的血管解剖变异(VIVA)并不常见,但可能会使手术复杂化并对治疗结果产生负面影响,但它们的发生率和临床影响尚未得到充分研究。我们旨在评估腹膜后肿瘤患者腹膜后大血管 VIVA 的发生率和临床影响。
我们回顾性分析了 2007 年 1 月至 2016 年 10 月期间接受腹膜后肿瘤切除术的所有儿科患者的影像学、手术、治疗和生存数据,比较了术前扫描与相应的术中观察结果,并对随后的手术结果进行了比较。
在 66 例肾、肾上腺和椎旁肿瘤患儿中,有 6 例(9%)存在腹膜后 VIVA。腹膜后 VIVA 仅存在于右侧肿瘤,且与术中并发症发生率显著相关(P=0.013)。虽然腹膜后 VIVA 的存在与生存结果没有直接关系,但 VIVA 患者的复发率更高(33%),而非 VIVA 患者的复发率(18.3%)(P=0.378),复发也与总体生存率和无事件生存率降低相关(P<0.001)。
腹膜后肿瘤患者中,腹膜后大血管 VIVA 的发生率为 9%。腹膜后 VIVA 与术中并发症和疾病复发的发生率较高有关,但与生存结果没有直接关系。
回顾性研究。
三级回顾性比较研究。